The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

PSYCHIATRIC USES OF INTRAVENOUS SODIUM AMYTAL

Published Online:https://doi.org/10.1176/ajp.99.3.411

Sodium amytal intravenously is a valuable diagnostic and therapeutic agent in psychiatry meriting more usage than given. Many patients in whom shock therapy or hypnosis cannot be utilized can be helped therapeutically or palliatively by suitable administration of this drug. It is convenient, safe and inexpensive, and can be used in stimulating doses, in narcosis regimen or as a powerful sedative.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.